Abstract

Cancer is a complex and devastating disease that affects millions of people worldwide. In this review article, we provide a comprehensive overview of the 31 types of cancer, their incidence, categories, treatment options, and survival rates. The first section describes the most common types of cancer, including carcinomas, sarcomas, leukemias, and lymphomas. We also highlight the genetic mutations that are associated with each type of cancer. The second section outlines the various treatment options for cancer, including surgery, radiation therapy, chemotherapy, immunotherapy, and stem cell transplantation. In the final section, we provide information on the survival rates and prognosis for each type of cancer. We conclude that while cancer remains a significant public health challenge, advances in research and treatment provide hope for improved outcomes and better quality of life for those affected by this disease.

2. Introduction

Cancer is one of the most significant public health challenges of our time, affecting millions of people worldwide. Despite tremendous advances in our understanding of the disease and its treatments, cancer remains a leading cause of death and disability around the world [1]. The term cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. This abnormal growth can occur in any part of the body, and the specific type of cancer is determined by the location and type of cell affected [2]. There are over 100 different types of cancer, but they can be broadly categorized into 31 different types. The incidence of each type of cancer varies, with some being more common than others. Among the most common types of cancer are breast cancer, lung cancer, prostate cancer, colorectal cancer, and skin cancer. However, there are also several rare types of cancer that affect a smaller number of people [3]. The causes of cancer are complex and multifactorial, and there is no one single cause. However, many types of cancer are associated with genetic mutations, which can be inherited or acquired over the course of a person's life. Environmental factors, such as exposure to radiation, certain chemicals, and viruses, can also contribute to the development of cancer [4]. Treatment options for cancer vary depending on the type of cancer and the stage of the disease. The most common treatment options include surgery, radiation therapy, chemotherapy, immunotherapy, and stem cell transplantation. Advances in research and technology have led to the development of new and more effective treatments, improving survival rates and quality of life for many cancer patients [5].

However, despite these advances, cancer remains a challenging disease to treat. Survival rates and prognosis vary widely depending on the type of cancer and the stage at which it is diagnosed. Some types of cancer have high survival rates when caught early, while others have very low survival rates, even with treatment [6]. In this review article, we provide a comprehensive overview of the 31 types of cancer, their incidence, categories, treatment options, and survival rates. Our goal is to provide readers with a deeper understanding of this complex disease and the various factors that contribute to its development and progression. We also hope to provide information on the latest treatment options and research advances, giving hope to those affected by cancer and their families.

3. Categories of Cancers

Cancer is a complex disease that can arise from different types of tissues in the body. The 31 different types of cancer can be broadly categorized into five main groups: carcinomas, sarcomas, leukemias, lymphomas, and central nervous system cancers.

3.1. Carcinomas

Carcinomas are the most common type of cancer, accounting for about 80-90% of all diagnosed cases. They develop from cells that make up the skin or the lining of internal organs and glands. Examples of carcinomas include lung cancer, breast cancer, colon cancer, and prostate cancer [7].

3.2. Sarcomas

Sarcomas are cancers that develop from cells in the body's connective tissues, such as bone, cartilage, fat, and muscle. They are relatively rare, accounting for only about 1% of all cancer cases. Examples of sarcomas include osteosarcoma, chondrosarcoma, and liposarcoma [8].

3.3. Leukemias

Leukemias are cancers that begin in blood-forming cells in the bone marrow, which produce abnormal white blood cells that don't function properly. Leukemia is the most common cancer in children, and the eighth most common cancer in adults. Examples of leukemias include acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML) [9].

3.4. Lymphomas

Lymphomas are cancers that begin in the lymphatic system, which is part of the body's immune system. They occur when abnormal lymphocytes (a type of white blood cell) grow out of control. There are two main types of lymphomas: Hodgkin lymphoma and non-Hodgkin lymphoma [10].

3.5. Central nervous system cancers

Central nervous system (CNS) cancers are those that develop in the brain and spinal cord. They are relatively rare, accounting for only about 2% of all cancer cases. Examples of CNS cancers include glioblastoma, astrocytoma, and ependymoma [11]. Understanding the different categories of cancer can help in the development of targeted and effective treatment strategies.

4. Carcinomas

Carcinomas are the most common type of cancer, with an estimated 80-90% of all diagnosed cancer cases being carcinomas [7]. These cancers originate from epithelial cells, which are the cells that line the surfaces and cavities of the body. There are two main types of carcinomas: squamous cell carcinomas and adenocarcinomas [12]. Squamous cell carcinomas are cancers that develop from squamous cells, which are flat, scale-like cells that make up the outermost layer of the skin, as well as the lining of some organs, such as the lungs, esophagus, and cervix. These cancers are often linked to chronic exposure to UV radiation from the sun or tanning beds, as well as smoking or other environmental factors. Examples of squamous cell carcinomas include lung cancer, head and neck cancer, and skin cancer. Adenocarcinomas, on the other hand, develop from glandular cells that produce and secrete fluids, such as mucus, enzymes, or hormones. These cancers can occur in many organs, including the breast, lung, colon, prostate, and pancreas. Adenocarcinomas can be difficult to detect in their early stages, as they often do not produce symptoms until they have advanced. Risk factors for adenocarcinomas can vary depending on the specific organ affected, but may include genetics, lifestyle factors, and environmental exposures. Treatment options for carcinomas depend on the type and stage of the cancer, as well as the patient's overall health and preferences. Treatment options may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and/or a combination of these approaches. In some cases, hormone therapy may also be used for cancers that are hormone-sensitive, such as breast or prostate cancer.Overall, early detection and prompt treatment are key to improving outcomes for patients with carcinomas. Regular screening and monitoring for cancer risk factors can help identify cancers in their early stages, when they are more treatable. Additionally, ongoing research is focused on developing new and more effective treatments for these common and often deadly cancers. Sarcomas are a rare but serious type of cancer that develop from connective tissues in the body, including bone, cartilage, fat, and muscle. These cancers can occur in any part of the body and are often classified based on the specific type of tissue or cell from which they originate [13]. Osteosarcoma is a type of bone cancer that typically affects children and young adults. It develops from osteoblasts, the cells that form new bone tissue. Common symptoms of osteosarcoma include bone pain, swelling, and fractures, and treatment may involve surgery, chemotherapy, and/or radiation therapy [14].

Chondrosarcoma is a cancer that develops from cartilage cells and typically affects adults. This type of cancer often grows slowly and may not cause symptoms until it has advanced. Treatment options for chondrosarcoma may include surgery, radiation therapy, and/or chemotherapy [15]. Liposarcoma is a cancer that develops from fat cells and typically affects adults. This type of cancer can occur anywhere in the body, but is most commonly found in the limbs, abdomen, and retroperitoneum (the area behind the abdominal cavity). Treatment options for liposarcoma may include surgery, radiation therapy, and/or chemotherapy [16]. Because sarcomas are relatively rare, they can be difficult to diagnose and treat. Symptoms of sarcomas may vary depending on the location and type of cancer, but may include pain, swelling, and/or a lump or mass. Diagnosis may involve imaging tests, such as X-rays, CT scans, or MRI scans, as well as a biopsy to confirm the presence of cancer cells. Treatment options for sarcomas may vary depending on the location and stage of the cancer, as well as the patient's overall health and preferences. Surgery is often the mainstay of treatment for localized sarcomas, while chemotherapy and/or radiation therapy may be used to treat more advanced cancers or cancers that have spread to other parts of the body. Overall, early detection and prompt treatment are key to improving outcomes for patients with sarcomas. Ongoing research is focused on developing new and more effective treatments for these rare and often difficult-to-treat cancers.

5. Leukemias

Leukemias are a group of cancers that affect the blood and bone marrow, the spongy tissue inside bones where blood cells are produced. Leukemia begins when blood cells that are not fully matured start to grow abnormally, dividing and multiplying rapidly and uncontrollably. These abnormal cells, called leukemia cells, can interfere with the normal function of blood cells, leading to symptoms such as fatigue, weakness, infections, and bleeding [17]. There are four main types of leukemia: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). ALL is the most common type of leukemia in children, but it can also occur in adults. It develops from immature lymphocytes, a type of white blood cell. Symptoms of ALL may include fatigue, fever, easy bruising or bleeding, and frequent infections. Treatment options for ALL typically include chemotherapy, radiation therapy, and/or stem cell transplantation [18]. AML is a type of leukemia that develops from immature myeloid cells, which are a type of white blood cell. AML is more common in adults than in children. Symptoms of AML may include fatigue, weakness, fever, and easy bruising or bleeding. Treatment options for AML may include chemotherapy, stem cell transplantation, and/or targeted therapy [19]. CLL is a type of leukemia that develops from abnormal lymphocytes. It typically affects adults and progresses slowly, with many people not requiring treatment for years. Symptoms of CLL may include fatigue, weakness, swollen lymph nodes, and frequent infections. Treatment options for CLL may include chemotherapy, targeted therapy, and/or stem cell transplantation [20].

CML is a type of leukemia that develops from abnormal white blood cells called myeloid cells. CML is most commonly diagnosed in adults and progresses slowly, often not causing symptoms for many years. Symptoms of CML may include fatigue, weakness, and enlarged spleen or liver. Treatment options for CML may include targeted therapy, chemotherapy, and/or stem cell transplantation [21]. Treatment options for leukemias depend on the type and stage of the cancer, as well as the patient's overall health and preferences. Treatment may involve chemotherapy, radiation therapy, targeted therapy, immunotherapy, and/or stem cell transplantation. For some types of leukemia, such as CLL, a "watch and wait" approach may be appropriate if the cancer is not causing symptoms and is not progressing rapidly. Overall, ongoing research is focused on developing new and more effective treatments for leukemias, including targeted therapies that can attack cancer cells more precisely and with fewer side effects. Early detection and prompt treatment are key to improving outcomes for patients with leukemias.

6. Lymphomas

Lymphomas are cancers that develop in the lymphatic system, which is part of the body's immune system. The lymphatic system includes lymph nodes, spleen, thymus gland, and bone marrow, which work together to produce and circulate lymphocytes, a type of white blood cell that helps to fight infections and other diseases. Lymphomas are divided into two main types: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). HL is a relatively rare type of lymphoma, accounting for about 10% of all diagnosed cases. It develops from abnormal B lymphocytes, a type of white blood cell that helps fight infections. HL is characterized by the presence of large, abnormal cells called Reed-Sternberg cells, which can be seen under a microscope. Symptoms of HL may include enlarged lymph nodes, fever, night sweats, and weight loss. Treatment options for HL may include chemotherapy, radiation therapy, and/or immunotherapy [22]. NHL is a more common type of lymphoma, accounting for about 90% of all diagnosed cases. There are many different subtypes of NHL, which are classified based on the specific type of cell that is affected. Symptoms of NHL may include enlarged lymph nodes, fever, night sweats, and weight loss. Treatment options for NHL may include chemotherapy, radiation therapy, immunotherapy, and/or stem cell transplantation [23]. Treatment options for lymphomas depend on the type and stage of the cancer, as well as the patient's overall health and preferences. For some types of lymphoma, such as early-stage HL, a combination of chemotherapy and radiation therapy may be effective. For more advanced or aggressive lymphomas, more intensive treatment may be needed, such as high-dose chemotherapy followed by stem cell transplantation. Overall, ongoing research is focused on developing new and more effective treatments for lymphomas, including targeted therapies and immunotherapies that can attack cancer cells more precisely and with fewer side effects. Early detection and prompt treatment are key to improving outcomes for patients with lymphomas.

7. Central nervous system cancers

Central nervous system (CNS) cancers are a group of cancers that affect the brain and spinal cord. They are relatively rare, accounting for about 1.4% of all diagnosed cancers. There are two main types of CNS cancers: primary CNS cancers, which start in the brain or spinal cord, and metastatic CNS cancers, which spread to the brain or spinal cord from other parts of the body [24]. Primary CNS cancers can be further divided into two main types: gliomas and meningiomas. Gliomas develop from glial cells, which provide support and protection for neurons in the brain and spinal cord. There are several subtypes of gliomas, including astrocytomas, oligodendrogliomas, and ependymomas. Meningiomas develop from the meninges, which are the membranes that cover the brain and spinal cord. Symptoms of CNS cancers may include headaches, seizures, changes in vision or hearing, and problems with balance or coordination. Treatment options for CNS cancers depend on the type and stage of the cancer, as well as the patient's overall health and preferences. Treatment may involve surgery, radiation therapy, chemotherapy, targeted therapy, and/or immunotherapy. For some types of CNS cancers, such as low-grade gliomas, a "watch and wait" approach may be appropriate if the cancer is not causing symptoms and is not progressing rapidly. Metastatic CNS cancers are more common than primary CNS cancers and are typically treated differently. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, and/or immunotherapy, depending on the type and stage of the cancer and the patient's overall health. Overall, ongoing research is focused on developing new and more effective treatments for CNS cancers, including targeted therapies and immunotherapies that can attack cancer cells more precisely and with fewer side effects. Early detection and prompt treatment are key to improving outcomes for patients with CNS cancers.

7.1. All Treatment Methods

There are several treatment methods for cancer, which may be used alone or in combination depending on the type and stage of cancer, as well as the patient's overall health and preferences. These treatments include:

7.2 Surgery

Surgery is a common treatment for cancer that involves the removal of the tumor and surrounding tissue. It is most effective for solid tumors that have not spread to other parts of the body.

7.3 Radiation therapy

Radiation therapy uses high-energy radiation to kill cancer cells and shrink tumors. It can be used as the main treatment or in combination with surgery or chemotherapy.

7.4 Chemotherapy

Chemotherapy uses drugs to kill cancer cells throughout the body. It may be used before or after surgery, or as the main treatment for cancers that have spread to other parts of the body.

7. 5 Immunotherapy

Immunotherapy works by boosting the body's immune system to recognize and attack cancer cells. It is often used to treat cancers that have spread to other parts of the body, and is sometimes combined with other treatments.

7.6 Targeted therapy

Targeted therapy uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. It is often used for cancers that have specific genetic mutations.

7.7 Hormone therapy

Hormone therapy is used to treat cancers that are hormone-sensitive, such as breast and prostate cancer. It works by blocking the hormones that fuel the growth of cancer cells.

7.8 Stem cell transplant

Stem cell transplant, also known as bone marrow transplant, may be used to treat certain types of cancer, such as leukemia, lymphoma, and multiple myeloma. It involves replacing diseased or damaged bone marrow with healthy stem cells to promote the growth of new, healthy blood cells. It is important to note that the best treatment approach for cancer depends on many factors, including the type and stage of cancer, the patient's overall health, and their individual preferences. A multi-disciplinary team of doctors and specialists will work together to create an individualized treatment plan for each patient.

7.9 The most promising and cutting-edge cancer treatments

Recent years have seen significant advancements in cancer treatment, with promising and cutting-edge therapies currently being developed and tested. In this section, we will explore some of the most innovative and exciting cancer treatments on the horizon.

7.9.1. Targeted Therapies

Targeted therapies are designed to specifically target cancer cells, while minimizing damage to healthy cells. These therapies work by targeting specific proteins or other molecules that are unique to cancer cells. Some examples of targeted therapies include small molecule inhibitors and monoclonal antibodies. These therapies have already shown promising results in the treatment of various types of cancer, including breast cancer, lung cancer, and melanoma.

7.9.2. Immunotherapy

Immunotherapy is a type of cancer treatment that harnesses the power of the immune system to fight cancer. This therapy works by activating or enhancing the immune system's ability to recognize and attack cancer cells. There are several types of immunotherapy, including checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. Immunotherapy has shown remarkable success in treating various types of cancer, including melanoma, lung cancer, and bladder cancer.

7.9.3. Gene Therapy

Gene therapy involves the delivery of genetic material to cells, either to replace or repair faulty genes or to help the body better fight cancer. There are several types of gene therapy, including gene editing and gene transfer. The CRISPR-Cas9 gene editing technology has shown great promise in treating various types of cancer, by allowing researchers to selectively edit or delete genes that play a role in cancer growth.

7.8.4. Emerging Technologies

There are also several emerging technologies that are being developed for the treatment of cancer. One of these technologies is CAR-T cell therapy, which involves genetically engineering a patient's T cells to attack cancer cells. Another emerging technology is nanoparticle-based drug delivery, which involves delivering cancer drugs directly to tumors using nanoparticles. These technologies have the potential to revolutionize cancer treatment and improve outcomes for patients. In conclusion, there are several promising and cutting-edge cancer treatments currently being developed and tested. These therapies have the potential to improve cancer treatment outcomes and provide new hope for patients. However, it is important to continue to invest in research and development to further advance these therapies and bring them to market.

8. Target Therapies

Targeted therapies are designed to selectively target specific molecules or pathways that play a critical role in cancer cell growth and survival. They work by blocking the activity of these molecules or pathways, which can slow or stop the growth and spread of cancer cells. Compared to traditional chemotherapy, which can affect both cancer cells and healthy cells, targeted therapies are designed to spare healthy cells in the body and have fewer side effects [25]. One type of targeted therapy is monoclonal antibodies, which are designed to target specific molecules on the surface of cancer cells. Monoclonal antibodies are produced in a laboratory and can be designed to mimic the immune system's ability to recognize and attack specific cells. By targeting specific molecules on the surface of cancer cells, monoclonal antibodies can block their growth or trigger the immune system to attack them. Small molecule inhibitors are another type of targeted therapy that work by blocking specific molecules or pathways that are involved in cancer cell growth and survival. Small molecule inhibitors are typically administered orally, and they can be designed to target a wide range of molecules, including enzymes and signaling pathways. For example, some small molecule inhibitors target the epidermal growth factor receptor (EGFR) pathway, which is overactive in some types of cancer cells.

Immunotherapy is a type of targeted therapy that works by harnessing the power of the immune system to recognize and attack cancer cells. Checkpoint inhibitors are a type of immunotherapy that target proteins on cancer cells or immune cells that inhibit the immune system's ability to recognize and attack cancer cells. By blocking these proteins, checkpoint inhibitors can unleash the immune system to attack cancer cells. CAR T-cell therapy is another type of immunotherapy that involves collecting a patient's immune cells and genetically modifying them to specifically target cancer cells. The modified cells are then infused back into the patient's body, where they can attack cancer cells. This therapy has shown promising results in treating some types of blood cancers. Cancer vaccines are another type of immunotherapy that can stimulate the immune system to recognize and attack cancer cells. Cancer vaccines can be designed to target specific molecules on the surface of cancer cells or to activate the immune system to attack cancer cells. In summary, targeted therapies are a promising approach to treating cancer. They are designed to selectively target specific molecules or pathways that are involved in cancer cell growth and survival. Different types of targeted therapies can be used to treat different types of cancer, and they can be used in combination with other treatments, such as chemotherapy and radiation therapy. As with any cancer treatment, it is important for patients to discuss the potential benefits and risks of targeted therapies with their healthcare providers.

9. Immunotherapy

Immunotherapy is a type of cancer treatment that works by harnessing the body's immune system to recognize and attack cancer cells. The immune system is designed to identify and destroy abnormal cells, including cancer cells, but sometimes cancer cells can evade the immune system's defenses. Immunotherapy can help the immune system recognize and attack cancer cells more effectively. One type of immunotherapy is checkpoint inhibitors, which work by blocking proteins on cancer cells or immune cells that prevent the immune system from attacking cancer cells. These proteins are known as checkpoints, and they are designed to prevent the immune system from attacking healthy cells in the body. By blocking these checkpoints, checkpoint inhibitors can help the immune system recognize and attack cancer cells [26]. Another type of immunotherapy is CAR T-cell therapy, which involves collecting a patient's immune cells and genetically modifying them to specifically target cancer cells. The modified cells, known as chimeric antigen receptor (CAR) T cells, are then infused back into the patient's body, where they can seek out and destroy cancer cells [27]. Cancer vaccines are another type of immunotherapy that works by stimulating the immune system to recognize and attack cancer cells. Cancer vaccines can be designed to target specific molecules on the surface of cancer cells, which can help the immune system recognize and attack those cells [28].

Finally, there are also immune system modulators, which work by enhancing the activity of the immune system against cancer cells. These include interferons, interleukins, and other cytokines that can stimulate the immune system to attack cancer cells [29]. Immunotherapy has shown promising results in treating several types of cancer, including melanoma, lung cancer, and some types of leukemia and lymphoma. However, like all cancer treatments, immunotherapy can have side effects, including fatigue, flu-like symptoms, and inflammation. Some patients may also experience more serious side effects, such as autoimmune disorders, which occur when the immune system attacks healthy cells in the body. It is important for patients to discuss the potential benefits and risks of immunotherapy with their healthcare providers, as not all patients respond to this treatment and some may experience significant side effects. Additionally, researchers are continuing to study the effectiveness of immunotherapy and exploring new approaches to improve its ability to fight cancer.

10. Gene Therapy

Gene therapy is a type of cancer treatment that involves altering the genetic material of cancer cells to either correct or eliminate a specific genetic mutation that is driving their growth and survival. Gene therapy can also be used to enhance the immune system's ability to recognize and attack cancer cells. There are several types of gene therapy, including:

10.1. Insertion of normal genes

This approach involves inserting a normal copy of a gene into the cancer cells that have a mutated or missing version of that gene. This approach can help to restore the normal function of the gene, which can help to slow or stop the growth of cancer cells [30].

10.2. Inactivation of oncogenes

Oncogenes are genes that can cause cancer when they become overactive or mutated. Gene therapy can be used to inactivate these genes, which can help to stop the growth of cancer cells [31].

10.3. Introduction of suicide genes

Suicide genes are genes that can be activated in cancer cells to induce cell death. Gene therapy can be used to introduce these genes into cancer cells, which can help to eliminate them [32].

10.4. Modification of immune cells

Gene therapy can be used to modify immune cells, such as T cells, to recognize and attack cancer cells. This approach can be done using chimeric antigen receptor (CAR) T-cell therapy, which involves collecting and genetically modifying a patient's T cells to specifically target cancer cells [33]. One of the most promising areas of gene therapy for cancer treatment is the use of viral vectors to deliver therapeutic genes to cancer cells. Viral vectors are modified viruses that can deliver therapeutic genes to cancer cells. The most commonly used viral vectors are retroviruses, adenoviruses, and lentiviruses. These viruses have been modified so that they can deliver the therapeutic genes to cancer cells without causing disease. Once the viral vector has delivered the therapeutic genes to the cancer cells, the genes can begin to alter the behavior of the cells to slow or stop their growth [34]. While gene therapy has shown promising results in preclinical studies, there are still many challenges to overcome before it can become a widespread treatment for cancer. One of the major challenges is developing safe and effective viral vectors that can target cancer cells without damaging healthy cells. Additionally, gene therapy can have significant side effects, such as inflammation and damage to healthy cells. Therefore, more research is needed to optimize gene therapy for cancer treatment and to develop safer and more effective methods for delivering therapeutic genes to cancer cells.

11. Emerging technologies

Emerging technologies in cancer treatment refer to a variety of novel approaches that are being developed to improve cancer therapy. Here are some examples of emerging technologies in cancer treatment:

11.1. Nanotechnology

Nanoparticles can be designed to deliver drugs to specific cells or tissues, including cancer cells. These nanoparticles can be engineered to be highly selective in targeting cancer cells while leaving healthy cells unaffected. By encapsulating cancer drugs in nanoparticles, it may be possible to reduce the toxicity and side effects associated with chemotherapy [35].

11.2. Liquid biopsies

Liquid biopsies involve analyzing a patient's blood or other bodily fluids for the presence of circulating tumor cells, cell-free DNA, or other cancer biomarkers. This approach can provide a non-invasive way to monitor a patient's response to treatment and detect cancer recurrence earlier than conventional imaging techniques [36].

11.3. Artificial intelligence

AI algorithms can be trained to analyze large amounts of data, including genomic data, radiological images, and electronic medical records. This approach can help to identify patterns and biomarkers that are associated with specific types of cancer, which can improve the accuracy of cancer diagnosis and treatment [37].

11.4. CRISPR/Cas9

CRISPR/Cas9 is a gene-editing technology that can be used to modify the DNA of cancer cells. By selectively targeting cancer genes or pathways, CRISPR/Cas9 may be able to turn off genes that promote cancer growth or turn on genes that suppress tumor growth [38].

11.5. Oncolytic viruses

Oncolytic viruses are viruses that can selectively infect and kill cancer cells while sparing normal cells. These viruses can be engineered to replicate specifically in cancer cells, leading to their destruction. In addition, some oncolytic viruses can stimulate the immune system to attack cancer cells [39].

11.6. CAR-T cell therapy

CAR-T cell therapy involves collecting a patient's own immune cells, engineering them to recognize and attack cancer cells, and then infusing them back into the patient's body. This approach has shown promising results in treating certain types of blood cancers, such as leukemia and lymphoma [40]. These emerging technologies have the potential to revolutionize cancer treatment by improving the accuracy and effectiveness of cancer diagnosis and treatment. However, more research is needed to fully understand their safety and efficacy in human patients.

12. Discussion and Comparing four Methods

Targeted therapies, immunotherapy, gene therapy, and emerging technologies are all promising and rapidly evolving methods for the treatment of cancer. Each approach has its own strengths and weaknesses, and the best choice of treatment depends on the individual patient's situation. Targeted therapies and immunotherapy are currently the most established and widely used cancer treatments among the four approaches. Targeted therapies, as mentioned earlier, are a class of cancer treatments that focus on targeting specific molecules or genetic mutations that drive the growth and survival of cancer cells. In contrast, immunotherapy harnesses the power of the immune system to recognize and attack cancer cells. Both approaches have shown promising results in treating several types of cancer, and many patients have experienced long-lasting remissions. Gene therapy, on the other hand, is a newer and less established approach, but it has the potential to revolutionize cancer treatment. Gene therapy involves the modification of a patient's own cells to produce a therapeutic effect. This can be done in several ways, such as introducing a new gene to replace a defective one or modifying the patient's immune cells to specifically target cancer cells. While gene therapy has shown great promise in preclinical studies, there are still several technical and safety challenges that need to be addressed before it can be widely used in the clinic.

Emerging technologies, such as nanotechnology and artificial intelligence, are also showing promise in the field of cancer treatment. Nanoparticles can be designed to deliver drugs or other therapeutic agents directly to cancer cells, while leaving healthy cells unharmed. Artificial intelligence is being used to analyze large amounts of patient data to develop personalized treatment plans that are tailored to each patient's unique situation. However, these technologies are still in the early stages of development, and more research is needed to determine their safety and efficacy in cancer treatment. In terms of comparing the different approaches, each has its own unique advantages and disadvantages. Targeted therapies and immunotherapy have shown the most success in clinical trials and are currently the most established treatments. Gene therapy has the potential to cure cancer by targeting the underlying genetic mutations, but it is still a new and developing technology. Emerging technologies, such as nanotechnology and artificial intelligence, have the potential to revolutionize cancer treatment, but they are still in the early stages of development and require further research. Overall, the choice of treatment depends on several factors, including the type and stage of cancer, the patient's medical history and health status, and the potential risks and benefits of each treatment. It is important for patients to discuss their treatment options with their healthcare providers and to make an informed decision that is best for their individual situation.

References

1. American Cancer Society. Cancer Facts and Figures 2021. Atlanta: American Cancer Society; 2021.

2. National Cancer Institute. What Is Cancer? Available from: https://www.cancer.gov/about-cancer/understanding/what-is-cancer. Accessed February 19, 2023.

3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33.

4. American Cancer Society. What Causes Cancer? Available from: https://www.cancer.org/cancer/cancer-causes.html. Accessed February 19, 2023.

5. National Cancer Institute. Cancer Treatment. Available from: https://www.cancer.gov/about-cancer/treatment. Accessed February 19, 2023.

6. American Cancer Society. Survival Rates for Common Cancers. Available from: https://www.cancer.org/cancer/cancer-basics/survival-rates.html. Accessed February 19, 2023.

7. Alberg A J, & Ford JG. (2018). Primary Prevention of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (3rd Edition). Chest, 153(5), 946–971. https://doi.org/10.1016/j.chest.2018.02.015

8. American Cancer Society. (2022). Sarcoma. https://www.cancer.org/cancer/sarcoma.html

9. Leukemias: National Cancer Institute. (2021). Adult Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version. https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq

10. Lymphomas: American Cancer Society. (2022). Lymphoma. https://www.cancer.org/cancer/lymphoma.html

11. Central nervous system cancers: Central Brain Tumor Registry of the United States. (2022). CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019. https://www.cbtrus.org/statistics/2022/histology/index.html

12. Kasper Dennis L. et al. Harrison's Principles of Internal Medicine, 19th Edition, McGraw Hill Professional, 2015.

13. Madan V, Lear JT, &Szeimies R-M. Non-melanoma skin cancer. The Lancet 375, 673–685 (2010). https://doi.org/10.1016/S0140-6736(09)61196-X

14. Lee YJ, Lee SH, &Youk EG. Lung Squamous Cell Carcinoma: An Update. Archives of Pathology & Laboratory Medicine 140, 1130–1136 (2016). https://doi.org/10.5858/arpa.2015-0535-RA

15. Sahu SK. et al. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clinic Proceedings 96, 896–907 (2021). https://doi.org/10.1016/j.mayocp.2021.01.034

16. Davies G, Cornish J & White, A. Adenocarcinoma. in StatPearls (StatPearls Publishing, 2021). Available at: https://www.ncbi.nlm.nih.gov/books/NBK557690/.

17. American Cancer Society. (2022). What is Leukemia? https://www.cancer.org/cancer/leukemia/about/what-is-leukemia.html

18. National Cancer Institute. (2022). Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version. Retrieved from https://www.cancer.gov/types/leukemia/hp/adult-all-treatment-pdq

19. American Cancer Society. (2022). Treatment of Acute Myeloid Leukemia by Subtype. Retrieved from https://www.cancer.org/cancer/acute-myeloid-leukemia/treating/by-subtype.html

20. Leukemia & Lymphoma Society. (n.d.). Chronic Lymphocytic Leukemia. Retrieved from https://www.lls.org/leukemia/chronic-lymphocytic-leukemia/treatment

21. Reference: American Cancer Society. (2022). Treatment of Chronic Myeloid Leukemia (CML). Retrieved from https://www.cancer.org/cancer/chronic-myeloid-leukemia/treating/by-stage.html

22. Cheson BD, Fisher RI, Barrington SF, Cavalli F, and et al, J ClinOncol. 2014 Sep 20;32(27):3059-68. doi: 10.1200/JCO.2013.54.8800. Epub 2014 Aug 25. PMID: 25154821.

23. LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006 Mar 15;107(6):265-76. doi: 10.1182/blood-2005-06-2508. Epub 2005 Nov 17. PMID: 16293699.

24. American Brain Tumor Association. (2022). Types of Brain Tumors. https://www.abta.org/tumor_types/brain-tumor-types/

25. Graur D, Dessimoz C, &Tannier E. (2016). The unanswered questions of the human genome. Philosophical Transactions of the Royal Society B: Biological Sciences, 371(1701), 20150130. https://doi.org/10.1098/rstb.2015.0130

26. Hodi FS, ODay SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, ... &Boasberg PD. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. New England Journal of Medicine, 363(8), 711-723.

27. Kenderian SS, &Ruella M. (2020). CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products. Therapeutic Advances in Hematology, 11, 2040620720954957. https://doi.org/10.1177/2040620720954957

28. Disis ML, (2019). Immunotherapy in Breast Cancer: An Introduction. Breast Care, 14(1), 5-9. doi: 10.1159/000496125.

29. Pardoll DM, (2012). The blockade of immune checkpoints in cancer immunotherapy. Nature Reviews Cancer, 12(4), 252-264. doi: 10.1038/nrc3239.

30. Kohn DB, Dotti G, &Brentjens, R. (2021). Novel approaches to gene therapy for cancer. The Journal of Clinical Investigation, 131(1), e139085. https://doi.org/10.1172/JCI139085

31. Osborn MJ, & Kay MA. (2011). Gene therapy. The Journal of Pathology, 224(2), 491-500.

32. Strimpakos, A. S., &Syrw(2010). Clinical significance of angiogenesis in cancer progression and metastasis. European journal of internal medicine, 21(3), 165-171. doi: 10.1016/j.ejim.2010.02.010.

33. Maus M. V., & June, C. H. (2016). Making better chimeric antigen receptors for adoptive T-cell therapy. Clinical Cancer Research, 22(8), 1875-1884.

34. Ginn SL, Amaya AK, & Mason HS. (2018). Gene therapy: Advances, challenges and perspectives. Nature Reviews Drug Discovery, 17(4), 261-284. https://doi.org/10.1038/nrd.2017.243

35. Feng Q, Liu M, Liu Z, & Yang X. (2020). Recent advances in nanotechnology-based drug delivery systems for cancer treatment and diagnosis. Frontiers in Pharmacology, 11, 1302. doi: 10.3389/fphar.2020.01302.

36. Diaz LA, Jr &Bardelli, A. (2014). Liquid biopsies: genotyping circulating tumor DNA. Journal of clinical oncology, 32(6), 579-586. doi: 10.1200/JCO.2012.45.201.

37. Esteva A, Robicquet A, Ramsundar B, et al. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24-29. doi: 10.1038/s41591-018-0316-z.

38. Gajewski TF, & Schreiber H. (2018). Fuelling the engine of anti-tumour immunity: harnessing the power of the T-cell. Clinical & Experimental Immunology, 191(2), 133-134. https://doi.org/10.1111/cei.13108

39. Kaufman HL, Kohlhapp FJ, &Zloza, A. (2015). Oncolytic viruses: a new class of immunotherapy drugs. Nature reviews. Drug discovery, 14(9), 642–662. https://doi.org/10.1038/nrd4663

40. June CH, O Connor, RS Kawalekar, OU Ghassemi, S &Milone, MC. (2018). CAR T cell immunotherapy for human cancer Science 359(6382), 1361-1365.